Nature Search

Variations in DSG2: V56M, V158G and V920G are not pathogenic for arrhythmogenic right ventricular dysplasia/cardiomyopathy

Maximilian G Posch
Matthias J Posch
Cemil Özcelik
Research01 Dec 2008
Nature Clinical Practice Cardiovascular Medicine

Volume: 5, P: E1
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial

Rinnerthaler et al. perform a randomized phase 2 trial of neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in patients with early HER2-positive breast cancer and report positively on efficacy and safety.

Gabriel Rinnerthaler
Daniel Egle
Richard Greil
ResearchOpen Access16 Jan 2025
Nature Cancer

Volume: 6, P: 41-50
Evidence for CTLA4 as a susceptibility gene for dilated cardiomyopathy

Volker Ruppert
Thomas Meyer
Sabine Pankuweit
Research10 Feb 2010
European Journal of Human Genetics

Volume: 18, P: 694-699
High-resolution maps of critical loads for sulfur and nitrogen in China

Xiaodong Ge
Qian Yu
Jiming Hao
ResearchOpen Access31 May 2023
Scientific Data

Volume: 10, P: 1-9
How reliably can ultrasound help determine muscle and adipose tissue thickness in clinical settings? An assessment of intra- and inter-examiner reliability in the USVALID study

Arabella Fischer
Ricarda Hahn
Michael Hiesmayr
Research05 Jul 2021
European Journal of Clinical Nutrition

Volume: 76, P: 401-409
Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy

Thomas Meyer
Volker Ruppert
Sabine Pankuweit
Research15 Aug 2012
European Journal of Human Genetics

Volume: 21, P: 294-300

Quick links

Search

Variations in DSG2: V56M, V158G and V920G are not pathogenic for arrhythmogenic right ventricular dysplasia/cardiomyopathy

Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial

Evidence for CTLA4 as a susceptibility gene for dilated cardiomyopathy

High-resolution maps of critical loads for sulfur and nitrogen in China

How reliably can ultrasound help determine muscle and adipose tissue thickness in clinical settings? An assessment of intra- and inter-examiner reliability in the USVALID study

Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy

Search

Quick links

Search

Filter By:

Variations in DSG2: V56M, V158G and V920G are not pathogenic for arrhythmogenic right ventricular dysplasia/cardiomyopathy

Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial

Evidence for CTLA4 as a susceptibility gene for dilated cardiomyopathy

High-resolution maps of critical loads for sulfur and nitrogen in China

How reliably can ultrasound help determine muscle and adipose tissue thickness in clinical settings? An assessment of intra- and inter-examiner reliability in the USVALID study

Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy

Search

Quick links